Chromosomal microarray analysis as a first-tier clinical diagnostic test: Estonian experience

Chromosomal microarray analysis (CMA) is now established as the first-tier cytogenetic diagnostic test for fast and accurate detection of chromosomal abnormalities in patients with developmental delay/intellectual disability (DD/ID), multiple congenital anomalies (MCA), and autism spectrum disorders...

Descripción completa

Detalles Bibliográficos
Autores principales: Žilina, Olga, Teek, Rita, Tammur, Pille, Kuuse, Kati, Yakoreva, Maria, Vaidla, Eve, Mölter-Väär, Triin, Reimand, Tiia, Kurg, Ants, Õunap, Katrin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Periodicals, Inc. 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3960059/
https://www.ncbi.nlm.nih.gov/pubmed/24689080
http://dx.doi.org/10.1002/mgg3.57

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3960059/
https://www.ncbi.nlm.nih.gov/pubmed/24689080
http://dx.doi.org/10.1002/mgg3.57

Ejemplares similares